BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24098347)

  • 1. Association between inflammatory infiltrates and isolated monosomy 22/del(22q) in meningiomas.
    Domingues PH; Teodósio C; Otero Á; Sousa P; Ortiz J; Macias Mdel C; Gonçalves JM; Nieto AB; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
    PLoS One; 2013; 8(10):e74798. PubMed ID: 24098347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas.
    Tabernero M; Jara-Acevedo M; Nieto AB; Caballero AR; Otero A; Sousa P; Gonçalves J; Domingues PH; Orfao A
    BMC Med Genet; 2013 Oct; 14():114. PubMed ID: 24171707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles of meningiomas are associated with tumor cytogenetics and patient outcome.
    Tabernero MD; Maillo A; Gil-Bellosta CJ; Castrillo A; Sousa P; Merino M; Orfao A
    Brain Pathol; 2009 Jul; 19(3):409-20. PubMed ID: 18637901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein expression profile of meningioma cells is associated with distinct cytogenetic tumour subgroups.
    Domingues PH; Teodósio C; Otero Á; Sousa P; Gonçalves JM; Nieto AB; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
    Neuropathol Appl Neurobiol; 2015 Apr; 41(3):319-32. PubMed ID: 24612434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays.
    Tabernero MD; Maíllo A; Nieto AB; Diez-Tascón C; Lara M; Sousa P; Otero A; Castrillo A; Patino-Alonso Mdel C; Espinosa A; Mackintosh C; de Alava E; Orfao A
    Genes Chromosomes Cancer; 2012 Jun; 51(6):606-17. PubMed ID: 22371336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor infiltrating immune cells in gliomas and meningiomas.
    Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
    Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.
    Domingues PH; Teodósio C; Ortiz J; Sousa P; Otero A; Maillo A; Bárcena P; García-Macias MC; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
    Am J Pathol; 2012 Nov; 181(5):1749-61. PubMed ID: 22982440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.
    Kim JH; Lee SH; Rhee CH; Park SY; Lee JH
    J Neurooncol; 1998 Nov; 40(2):101-6. PubMed ID: 9892091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas.
    Lekanne Deprez RH; Riegman PH; van Drunen E; Warringa UL; Groen NA; Stefanko SZ; Koper JW; Avezaat CJ; Mulder PG; Zwarthoff EC
    J Neuropathol Exp Neurol; 1995 Mar; 54(2):224-35. PubMed ID: 7876890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
    Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
    Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal involvement secondary to -22 in human meningiomas.
    Rey JA; Bello MJ; de Campos JM; Kusak E; Moreno S
    Cancer Genet Cytogenet; 1988 Jul; 33(2):275-90. PubMed ID: 3383169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mapping of the long arm of chromosome 22 in human meningiomas.
    Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I
    Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
    Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
    Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic/molecular alterations of meningiomas and the signaling pathways targeted.
    Domingues P; González-Tablas M; Otero Á; Pascual D; Ruiz L; Miranda D; Sousa P; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
    Oncotarget; 2015 May; 6(13):10671-88. PubMed ID: 25965831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases.
    Ketter R; Henn W; Niedermayer I; Steilen-Gimbel H; König J; Zang KD; Steudel WI
    J Neurosurg; 2001 Oct; 95(4):601-7. PubMed ID: 11596954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.
    Maillo A; Orfao A; Espinosa AB; Sayagués JM; Merino M; Sousa P; Lara M; Tabernero MD
    Neuro Oncol; 2007 Oct; 9(4):438-46. PubMed ID: 17704362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningiomas: karyotypes and histological patterns.
    Lopez-Gines C; Piquer J; Cerda-Nicolas M; Barcia-Salorio J; Barcia-Marino C
    Clin Neuropathol; 1989; 8(3):130-3. PubMed ID: 2743649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.
    Rutland JW; Gill CM; Loewenstern J; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Shrivastava RK; Fowkes M
    Cancer Immunol Immunother; 2021 Jan; 70(1):169-176. PubMed ID: 32661686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.